Background : Dual chamber pacemakers (single chamber pacing dual chamber sensing cardiac pacemaker (VDD) and dual chamber pacing and sensing cardiac pacemaker (DDD)) are being used frequently in children and adolescents. The aim of this study was to verify the safety and performance of the VDD and DDD pacing systems, and to evaluate the differences between two pacing modes with regard to atrial sensing and tracking functions. Methods : In this study, we evaluated 14 patients with VDD pacing and 15 patients with DDD pacing between 1994 and 2000. In the patient group with VDD pacing, all had congenital or acquired atrioventricular (AV) block. In the patient group with DDD pacing, 11 had congenital or acquired AV block, three had sinus node dysfunction with AV conduction disturbance and one had idiopathic hypertrophic subaortic stenosis. Twentyeight devices were implanted in the subpectoral area using the transvenous route. After implantation the atrial tracking capabilities of the pacing systems were analyzed by telemetry, Holter monitoring, and treadmill exercise testing. Results : The mean age of patients in the VDD pacing group was younger. The percentage of congenital heart disease was higher in the DDD pacing group. There was no significant difference regarding fluoroscopy time during implantation and follow-up time between the two groups. During implantation, in the VDD pacing group the mean sensed atrial signal was 3.1 ± 1.3 mV and this decreased to 1.37 ± 0.68 mV ( P < 0.05) during follow-up. This pattern was also observed in DDD group (3 ± 2 mV vs 1.9 ± 1.5 mV, P < 0.05). Although the P wave measurement at implantation did not differ between the two groups, it was significantly higher in the DDD pacing group at the last control. Three patients with VDD pacing were reprogrammed to VVI or single chamber pacing and sensing, rate adaptive cardiac pacemaker because of complete loss of AV synchrony. There was no atrial sensing problem in the DDD pacing group. During the follow-up, one patient with VDD pacing developed diaphragmatic stimulation and required lead revision. In one patient with DDD pacing, venous thrombosis occurred in the right subclavian vein and was treated with thrombolytic therapy. During treadmill exercise testing, in one patient with VDD and one patient with DDD pacing temporary failure of atrial sensing occurred. At 24 h Holter monitoring, intermittent loss of atrial sensing was documented in two patients with VDD pacing. Conclusions : Dual chamber pacing in children with DDD or VDD pacemakers is a suitable method for bradycardia treatment. Atrial sensing problems may occur in VDD pacemakers. Therefore, DDD pacing mode should be preferred whenever suitable for the patient to maintain the AV synchrony.
quality of life, cardiac output and incidence of pacemaker syndrome. 2 Therefore, dual chamber pacemakers have been playing an increasing role in bradyarrhythmia therapy.
Single chamber pacing dual chamber sensing cardiac pacemaker (VDD) pacing mode may have advantages when compared to conventional dual chamber pacing (DDD) as it eliminates the need for an extra atrial lead and may make the implanter's work simpler and quicker. 3 In this pacing mode the maintenance of AV synchrony may be a problem with time. The purpose of this study was to verify the safety and performance of the VDD and DDD pacing systems, and to evaluate the differences between the two pacing modes with regard to atrial sensing and tracking functions.
Methods
Between 1994 and 2000, 29 children and young adults underwent implantation of a dual chamber pacing system at our department. The population in the study consisted of 18 males and 11 females, with mean age 14.5 ± 4.5 years (range 6 years to 23 years; median 14 years).
Fourteen patients (nine male, five female, mean age at implantation 10 ± 3.5 years, range 4-16 years; median 11 years) underwent implantation of VDD pacemakers. Indications for pacing in patients with VDD pacing included congenital high-grade AV block ( n = 9), surgical AV block ( n = 4), and inadvertent AV block after catheter ablation ( n = 1). Six patients with VDD pacing had congenital heart disease and four of them had undergone palliative or corrective heart surgery. Three patients had dilated cardiomyopathy (DCM) and one of them had DCM due to permanent reciprocating junctional tachycardia (PRJT). The mean follow-up was 35.3 ± 23.7 months in the patient group with VDD pacing (Table 1) .
Fifteen patients (eight male, seven female, mean age at implantation 13.8 ± 2 years, range 10-17 years; median 14 years) underwent implantation of DDD pacemakers. Indications for pacing in patients with DDD included surgical AV block ( n = 6), congenital AV block ( n = 5), sinus node dysfunction with AV conduction disturbance ( n = 3) and hypertrophic obstructive cardiomyopathy ( n = 1). Eleven patients with DDD pacing had congenital structural heart disease and nine of them had undergone palliative or corrective heart surgery. The mean follow-up was 32 ± 26.5 months in the patient group with DDD pacing (Table 2 ). In one patient with DDD pacing, DCM developed due to myocarditis in the follow-up. This patient was treated with medical therapy. No mode change was done during follow up.
Pacing leads and pacemakers
All single pass VDD pacing leads were steroid-eluting tined. The distance between the ventricular electrode tip and distal atrial electrode was 135 mm. In the patient group with VDD pacing three types of pacemakers were used (Table 1) .
In patients with DDD pacemakers three types of atrial and ventricular lead were implanted: passive tined atrial lead and screw-in ventricular lead in four patients, screw-in atrial lead and passive tined ventricular lead in six patients, both screw-in atrial lead and ventricular lead in four patients. All systems consisted of bipolar endocardial leads. In the patient group with DDD pacing three types of pacemakers were used (Table 2) .
Implantation procedure
Twenty-eight devices were implanted in the subpectoral area using the transvenous route. The vein used was the right subclavian vein in 16 patients and the left subclavian vein in 12 patients. In one patient who had undergone Fontan operation the device was implanted via the epicardial route. Lead impedance, spontaneous P and R wave, and pacing threshold measurements were obtained intraoperatively.
Follow-up data collection
The patients were discharged from hospital between 3-5 days after implantation and the follow-up controls were carried out ASD, atrial septal defect; AV, atrioventricular; c-TGA, corrected transposition; DCM, dilated cardiomyopathy; DDD, dual chamber pacing and sensing cardiac pacemaker; F, female; HCM, hypertrophic cardiomyopathy; HD, heart disease; M, male; MVR, mitral valve replacement; PS, pulmonary stenosis; VSD, ventricular septal defect; -, absent.
at the fourth week, third month, sixth month and every 6 months thereafter for a full analysis of the pacing systems. Evaluation included routine clinical examination, electrocardiogram, chest X-ray and the assessment of pacemaker functions with a pacemaker specified telemetry unit. After implantation, the atrial tracking capabilities of the pacing systems were assessed every 6 months or once a year by means of 24 h Holter monitoring and treadmill exercise testing.
Statistical analysis
Data are expressed as mean ± SD and median. Differences in p wave amplitude between implantation and the last visit were examined by Wilcoxon matched-pairs signed-ranks test. Comparative data were analyzed by using a χ 2 -test. Statistical significance is indicated by the calculated P values. A value of P < 0.05 was considered to be statistically significant.
Results
In this study, the mean age at implantation of patients with VDD pacing was lower than that of patients with DDD pacing ( P < 0.05) At implantation, the mean fluoroscopy time was 10.6 ± 5.4 min in the patient group with VDD pacing and 11.8 ± 2.8 min (NS) with DDD pacing. In patients with DDD pacing, congenital heart disease was determined frequently more than patients with VDD pacing ( P < 0.05). Follow-up periods were not different in two groups (35.3 ± 23.7 vs 32 ± 26.5, not significant). As a major complication, reposition of the lead was done in one patient with VDD pacing due to diaphragmatic stimulation. In one patient with DDD pacing venous thrombosis occurred in the right subclavian vein and was treated with oral thrombolytic therapy (Table 3 ). Other patients have not developed any late complications related to the pacing system. There were no significant changes in pacing impedance, ventricular sensing and pacing measurements in both groups.
In the patient group with VDD pacing the p wave amplitude at implantation was 3.1 ± 1.3 mV (range 6.6-1.6 mV, median 2.6 mV) and decreased to 1.37 ± 0.68 mV (range 0.35-2.8 mV, median 1 mV) at the last visit ( P < 0.05). This difference was detected between first evaluation and second evaluation ( P < 0.05) (Fig. 1) . After the second control the difference was not statistically important. During the follow-up, the percentage of AV synchronization was > 90% in seven patients with VDD pacing, between 70 and 90% in four patients, and lower than 70% in three patients. Three patients with VDD pacing were reprogrammed to VVIR because of complete loss of atrial sensing. One patient had been followed for 35 months in VDD pacing mode (patient 4) because of complete loss of atrial sensing during exercise testing and 24 h Holter monitoring. In this case VDD pacing mode was reprogrammed to VVIR pacing mode and this patient was followed 27 months in VVIR pacing mode. Afterwards, VVIR pacing mode was changed to VDD pacing mode due to regaining appropriate atrial sensing and the patient has been followed another 22 months in this mode.
In the patient group with DDD pacing the p wave amplitude (Fig. 2) at implantation was 3 ± 2 mV (range 1-6 mV, median 2.8 mV) and dropped to 1.9 ± 1.5 mV (range 1-2.5 mV, median 2 mV) at the last visit ( P < 0.05). There was no atrial sensing problem in the DDD pacing group that necessitated changing the pacing mode to VVIR.
The P wave undersensing was observed in both pacing modes during the exercise testing and the 24 h Holter monitoring. During the exercise testing, one patient from each group showed intermittent p wave undersensing. Therefore, in both patients, pacing modes were not changed. At the 24 h Holter monitoring, in two patients with VDD pacing temporary loss of atrial sensing was documented. In patients with VDD pacing mean p wave amplitude at the last visit was significantly lower compared to patients with DDD pacing ( P < 0.05). In patients with VDD pacing mode complete and temporary loss of AV synchrony was observed more than in patients with DDD pacing ( P < 0.05) ( Table 3 ).
Discussion
A pacemaker may determine two major components of cardiac performance: AV synchrony and rate increase. 4 The dual-chambered cardiac pacemaker is known as the physiological pacemaker because it has these components. The hemodynamic importance of preserving normal AV synchrony varies greatly depending on age and the presence or absence of organic heart disease. The contribution of atrium to stroke volume increases progressively with age. 5 Dual chamber pacemakers have been implanted with an increasing frequency in children and young adults recently. This increase in dual chamber pacing is resulted from improvements in atrial endocardial electrodes, increased experience with endocardial pacing in children and the smaller size of dual chamber generators. 6 A DDD pacing system requires the introduction and positioning of two separate electrode leads. One of the major problems related to the use of dual chamber pacing is that it is not possible to place reliable atrial and ventricular electrodes. In small children, the presence of two electrodes in the subclavian vein or vena cava superior might present a high risk for thrombosis and venous occlusion. 7 Another rationale for use of DDD pacing is if there is the inability to reach the atrium or ventricle via vascular access, as VDD pacing is not applicable in that situation. Although our patients with DDD pacing were generally young adults, in one of these patients venous thrombosis occurred. This patient was not in need of invasive reintervention and was treated with anticoagulant therapy. This was a very minor complication and there were no complications requiring pacemaker revision or change of pacing mode. In several reports the complication rate with DDD pacing was higher than with single chamber pacing. 8 We did not observe any major complication that necessitated revision because of our older patient age group, use of active fixation leads in most cases and the short period of follow-up time.
Single chamber pacing dual chamber sensing cardiac pacemaker pacing is an ideal mode of pacing for patients with complete heart block and normal sinus node function because it allows preservation of normal AV synchrony. 9 A VDD pacing system may use a single lead with a ventricular electrode at the tip and at least one atrial ring electrode. 10 This makes the implantation quicker, simpler and safer and reduces the time of fluoroscopy and incidence of electrode dislocation. The fluoroscopy time during implantation did not show any statistical significance compared to DDD implants in our study. The disadvantages of VDD system are that atrial stimulation is impossible and that the diameter of the single pass lead is somewhat larger. 3 In our study, patients with VDD pacing were younger than patients with DDD pacing, as we have preferred this mode of pacing in small children. Even though the single lead electrode has rarely been dislodged in VDD pacing system, in one patient with VDD pacing lead revision was made because of development of diaphragmatic stimulation due to electrode dislocation. As there is no active fixation lead suitable for VDD pacing, their use is not possible with VDD pacemakers.
In dual chambered cardiac pacing, AV synchronization is quite important. Atrial sensing plays a central role in singlelead VDD pacemakers. Intermittent atrial undersensing is common in these pacemakers. 11 Previous studies have demonstrated a gradual decrease in the P wave amplitude during the follow-up period. [12] [13] [14] [15] [16] [17] [18] Our study also demonstrated that in both pacing modes there were significant differences in atrial signal measurements in the period between implantation and the last visit ( P < 0.05). The P wave measurements in the DDD group were better than those in the VDD group at the last control. Several major factors may affect the detection of intra-atrial signals. These include the configuration of the lead space between the electrodes, electrode size, and the interaction between atrial muscle and electrode (aging and fibrosis). 15 In particular, sensing characteristics may deteriorate because of scarring related to cardiac surgery. 18 Moreover, in some of our patients with VDD pacing, intermittent P wave undersensing occurred during the exercise testing, but these problems were temporary and there was no need to change pacing mode. In three patients with VDD pacing, the pacing mode was reprogrammed to VVIR pacing mode due to severe P wave undersensing and complete loss of AV synchronization. Furthermore, in some of the patients with VDD pacing, the percentage of AV synchronization gradually reduced during the follow-up period, but this was temporary.
Unlike patients with VDD pacing, all patients with DDD pacing remained in DDD pacing mode during long-term follow-up. In eight of them the mean follow-up time was 53.4 ± 17.2 months (range 24-67 months). During the exercise testing only one patient showed temporary loss of AV synchronization. Although we did not observe any significant relationship between the congenital or acquired heart disease and loss of AV synchrony in VDD pacing group, in recent years we have been preferring DDD pacing in this patient group to prevent the loss of atrioventricular synchrony, which would be very harmful.
In conclusion, dual chamber pacing in children with VDD or DDD pacemakers should be the preferred method for bradycardia treatment. In small children with complete AV block and normal sinus node function, VDD pacing mode may be an alternative to DDD to lessen the vascular damage. Loss of AV synchrony is a difficult problem that may occur in VDD pacemakers with time even at the most appropriate indications. Therefore, DDD pacing mode should be preferred whenever suitable to maintain the AV synchrony, especially in patients with cardiac disorders.
